Jump Financial’s Oric Pharmaceuticals ORIC Stock Holding History

Jump Financial’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42M	Buy	+131,400	New	+$1.19M	0.01%	1026
2024 Q3	–	Sell	-19,723	Closed	-$139K	–	1994
2024 Q2	$139K	Buy	+19,723	New	+$177K	﹤0.01%	1610
2023 Q4	–	Sell	-32,149	Closed	-$195K	–	2109
2023 Q3	$195K	Buy	32,149 +16,449	+105%	+$135K	0.01%	1536
2023 Q2	$122K	Sell	15,700 -8,649	-36%	-$49.1K	﹤0.01%	1622
2023 Q1	$139K	Buy	+24,349	New	+$127K	0.01%	1389
2022 Q2	–	Sell	-40,000	Closed	-$213K	–	1914
2022 Q1	$213K	Buy	+40,000	New	+$360K	0.01%	1269

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jump Financial's ORIC Position: Q2 2026 in Review

Jump Financial opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 131,400 shares worth $1.42M. The stake represents 0.01% of the portfolio and ranks #1026 among its holdings. This is a return to the name: Jump Financial previously reported a position in ORIC as recently as Q2 2024.

Jump Financial first reported a position in ORIC in Q1 2022 and has held it in 6 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

Jump Financial held 131,400 shares of Oric Pharmaceuticals worth $1.42M as of Q2 2026.
Oric Pharmaceuticals was a new Jump Financial position in Q2 2026.
Oric Pharmaceuticals made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1026 holding.
Jump Financial first reported a position in Oric Pharmaceuticals in Q1 2022 and has held it in 6 quarters since.
180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.